Kuriakose Emil sold TERN
May 5, 2026 · Form 4 insider transaction
Kuriakose Emil sold 24,562 shares of Terns Pharmaceuticals Inc at $53.00 per share, a transaction worth $1.30M. The trade was recorded as u and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
Includes 842 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan since the reporting person's Form 4 filed on April 2, 2026.; On March 24, 2026, Terns Pharmaceuticals, Inc. (the "Issuer") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Merck Sharp & Dohme LLC ("Merck") and Thailand Merger Sub, Inc. (the "Purchaser"), a wholly owned subsidiary of Merck. Pursuant to the Merger Agreement, the Purchaser completed a tender offer for the shares of the Issuer's common stock (the "Shares"). In exchange for each Share, tendering shareholders will receive $53.00 per Share (the "Merger Consideration"), payable in cash, net to the seller, and without interest, subject to any applicable withholding taxes, as described more fully in the Schedule 14D-9 filed by the Issuer on April 7, 2026.